shopping cart Your cart is empty
  • Home
  • Healthcare
  • Human Rabies Treatment Market By Product Type (Top 3 Countries, Cell Culture Vaccines, Rabies Immunoglobulin, Nerve Tissue Vaccine...

Human Rabies Treatment Market By Product Type (Top 3 Countries, Cell Culture Vaccines, Rabies Immunoglobulin, Nerve Tissue Vaccines), By Treatment Type (Top 3 Countries, Pre-Exposure Immunization, Post-Exposure Prophylaxis) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Published By: Brisk Insights | Published On: May 20, 2022

 

Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. Factors such growing treatment awareness and rising initiatives of government organizations in prevention of rabies are primarily driving the growth of human rabies treatment market globally.

 

The report titled “Human rabies treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall human rabies treatment market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on product type, treatment type and different geographical regions.  Geographically, the global human rabies treatment market is studied for the following regional markets:   

 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of MEA

 

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

 

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global human rabies treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global human rabies treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global human rabies treatment market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.   

   

Thus, the research study provides a holistic view of the global human rabies treatment market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

 

Based on product type, the global human rabies treatment market is segmented as follows:  

 

  • Cell Culture Vaccines
  • Rabies Immunoglobulin
  • Nerve Tissue Vaccines
  • Other

 

Rabies is a life-threatening viral disease that attacks the nervous system. It is usually spread to humans via the saliva of an infected animals. The rabies virus is generally transmitted through bites and scratches from infected animals. Human rabies treatment market is categorized on the basis of product type such as cell culture vaccines, rabies immunoglobulin, nerve tissue vaccines and other. It is estimated that cell culture vaccines will show significant market growth during forecast period due to its safety, high immunogenicity, fewer adverse effects and negligible allergic reactions compared to other types of human rabies treatment. Human diploid cell strain vaccine (HDCV) is first cell culture vaccine but to overcome its higher cost, purified chicken embryo cell vaccine (PCECV) and purified vero cell culture rabies vaccine (PVRV) are available around the world by international pharmaceutical companies.

 

Based on treatment type, the global human rabies treatment market is segmented as follows:  

 

  • Pre-exposure Immunization
  • Post-exposure Prophylaxis

 

Rabies is a life-threatening illness spread via the saliva of an infected animals. The rabies virus is generally transmitted through bites and scratches from infected animals. Based treatment type, global rabies treatment market is segmented as pre-exposure immunization and post-exposure prophylaxis. It is estimated that pre-exposure immunization will show market growth during forecast period. As pre-exposure immunization is recommended for laboratory workers handling rabies and rabies related viruses, people whose activities might bring them into direct contact with animals and travelers to rabies-affected remote areas. It is studied that demand for post-exposure prophylaxis is increase in developing countries because post-exposure prophylaxis is the only safe and effective treatment available in market to prevent exposed persons from getting rabies. Post-exposure prophylaxis preferably involve management of animal bite wound, passive immunization and active immunization. According to world health organization (WHO), average cost of rabies post-exposure prophylaxis (PEP) is US$ 40 in Africa and US$ 49 in Asia. Every year, more than 15 million people worldwide receive a post-bite vaccination.

 

For the purpose of this study, the global human rabies treatment market is categorized into:

 

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

 

According to World health Organization (WHO), human rabies is present in 150 countries and territories and on all continents, except for Antarctica; and more than 10,000 people die each year from rabies. Globally, it is estimated that human mortality is highest in Asia, closely followed by Africa. According to Center for Disease Control and Prevention (CDC), human rabies is rare in United States with 1 to 3 cases reported annually. It is studied that, demand for pre-exposure immunization is highest in North America; United States is major regional market in North America. It is estimated that, Asia Pacific will show highest market growth during forecast period due to the increasing initiatives of government agencies and private organizations for prevention of rabies, populous countries, growing healthcare awareness and developing economic condition would expected to assist human rabies treatment market growth.

 

Chapter 1 Preface


1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

 

Chapter 2 Executive Summary


2.1 Global Human Rabies Treatment Market Snapshot
2.2 Global Human Rabies Treatment Market, by Product Type
2.3 Global Human Rabies Treatment Market, by Treatment Type, 2016 (US$ Bn)
2.4 Global Human Rabies Treatment Market Share, by Geography, 2016 (Value %)

 

Chapter 3 Human Rabies Treatment Market Analysis


3.1 Global Human Rabies Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Human Rabies Treatment Market

 

Chapter 4 Global Human Rabies Treatment Market, by Product Type


4.1 Overview
4.2 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Product Type
4.3 Top 3 Countries
4.4 Cell Culture Vaccines
4.5 Rabies Immunoglobulin
4.6 Nerve Tissue Vaccines
4.7 Other

 

Chapter 5 Global Human Rabies Treatment Market, by Treatment Type


5.1 Overview
5.2 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Treatment Type
5.3 Top 3 Countries
5.4 Pre-Exposure Immunization
5.5 Post-exposure prophylaxis

 

Chapter 6 Global Human Rabies Treatment Market, By Geography


6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.2.2 North America Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.2.3 North America Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.3.2 Europe Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.3.3 Europe Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.4.1 Asia Pacific Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.4.2 Asia Pacific Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.4.1 Asia Pacific Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.5.2 Latin America Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.5.3 Latin America Human Rabies Treatment Market, by Country, 2015- 2025 (US$)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Human Rabies Treatment Market, by Product Type, 2015- 2025 (US$)
6.6.2 Middle East and Africa Human Rabies Treatment Market, by Treatment Type, 2015- 2025 (US$)
6.6.3 Middle East and Africa Human Rabies Treatment Market, by Country, 2015- 2025 (US$)

 

Chapter 7 Company Profiles


7.1 Bio Med Pvt. Ltd.
7.2 Biological E Ltd.
7.3 Cadila Healthcare
7.4 CSC Pharmaceuticals International
7.5 GlaxoSmithKline GmbH
7.6 Grifols S.A.
7.7 Kamada Ltd.
7.8 Kedrion S.p.A.
7.9 Novartis International AG
7.10 Sanofi Pasteur SA
7.11 Serum institute of India

TABLE 1 Market Positioning of Key Players in Global Human Rabies Treatment Market
TABLE 2 Global Human Rabies Treatment Market, by Product Type, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Human Rabies Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 4 Global Human Rabies Treatment Market, by Treatment Type, 2015 – 2025 (US$ Bn)
TABLE 5 Top 3 Countries in Global Human Rabies Treatment Market, by Treatment Type 2015 – 2025 (US$ Bn)
TABLE 6 Global Human Rabies Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 7 North America Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 8 North America Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
TABLE 9 North America Human Rabies Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 10 Europe Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 11 Europe Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
TABLE 12 Europe Human Rabies Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Asia Pacific Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 14 Asia Pacific Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
TABLE 15 Asia Pacific Human Rabies Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 16 Latin America Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 17 Latin America Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
TABLE 18 Latin America Human Rabies Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 19 Middle East and Africa Human Rabies Treatment Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 20 Middle East and Africa Human Rabies Treatment Market, by Treatment Type, 2015-2025 (US$ Bn)
TABLE 21 Middle East and Africa Human Rabies Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 22 Bio Med Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 23 Biological E Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 24 Cadila Healthcare: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 25 CSC Pharmaceuticals International: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 26 GlaxoSmithKline GmbH: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 27 Grifols S.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 28 Kamada Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 29 Kedrion S.p.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 30 Novartis International AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 31 Sanofi Pasteur SA: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 32 Serum institute of India: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

FIG. 1 Human Rabies Treatment Market: Research Methodology
FIG. 2 Global Human Rabies Treatment Market, by Product Type, 2016 (US$ Bn)
FIG. 3 Global Human Rabies Treatment Market, by Treatment Type, 2016 (US$ Bn)
FIG. 4 Global Human Rabies Treatment Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Geography, 2016
FIG. 6 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Product type, 2016
FIG. 7 Global Cell Culture Vaccines Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Rabies Immunoglobulin Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Nerve Tissue Vaccines Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Other Human Rabies Treatment Market, 2015 – 2025 (US$ Bn)
FIG. 11 Attractive Investment Proposition: Global Human Rabies Treatment Market, by Treatment Type, 2016
FIG. 12 Global Rabies Pre-Exposure Immunization Market, 2015 – 2025 (US$ Bn)
FIG. 13 Global Rabies Post-exposure prophylaxis Market, 2015 – 2025 (US$ Bn)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)